Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)

Cells Studied

  • 6 Cells
HMS LINCS ID Name LINCS ID Alternative ID
50105-2 BT-20 LCL-1476
50108-2 BT-549 LCL-1310
50211-2 HCC1806 LCL-1960
50216-2 HCC38 LCL-1334
50219-2 HCC70 LCL-1335
50238-2 Hs 578T LCL-1315
  • 6 Cells